These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 31831121)
1. The Role of Nonenzymatic Post-translational Protein Modifications in Uremic Vascular Calcification. Lim K; Kalim S Adv Chronic Kidney Dis; 2019 Nov; 26(6):427-436. PubMed ID: 31831121 [TBL] [Abstract][Full Text] [Related]
2. Carbamylation and glycation compete for collagen molecular aging in vivo. Nicolas C; Jaisson S; Gorisse L; Tessier FJ; Niquet-Léridon C; Jacolot P; Pietrement C; Gillery P Sci Rep; 2019 Dec; 9(1):18291. PubMed ID: 31797985 [TBL] [Abstract][Full Text] [Related]
3. Relevance of oxidative and carbonyl stress to long-term uremic complications. Miyata T; Kurokawa K; van Ypersele de Strihou C Kidney Int Suppl; 2000 Aug; 76():S120-5. PubMed ID: 10936808 [TBL] [Abstract][Full Text] [Related]
4. The Role of Vitamin K in Vascular Calcification. Cozzolino M; Fusaro M; Ciceri P; Gasperoni L; Cianciolo G Adv Chronic Kidney Dis; 2019 Nov; 26(6):437-444. PubMed ID: 31831122 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic Interventions for Advanced Glycation-End Products and its Receptor- Mediated Cardiovascular Disease. Prasad K; Tiwari S Curr Pharm Des; 2017; 23(6):937-943. PubMed ID: 27719648 [TBL] [Abstract][Full Text] [Related]
7. Cellular mechanisms and consequences of glycation in atherosclerosis and obesity. López-Díez R; Shekhtman A; Ramasamy R; Schmidt AM Biochim Biophys Acta; 2016 Dec; 1862(12):2244-2252. PubMed ID: 27166197 [TBL] [Abstract][Full Text] [Related]
8. Defective interplay between mTORC1 activity and endoplasmic reticulum stress-unfolded protein response in uremic vascular calcification. Panda DK; Bai X; Sabbagh Y; Zhang Y; Zaun HC; Karellis A; Koromilas AE; Lipman ML; Karaplis AC Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1046-F1061. PubMed ID: 29357413 [TBL] [Abstract][Full Text] [Related]
9. Advanced Glycation End Products and Their Involvement in Cardiovascular Disease. Yubero-Serrano EM; Pérez-Martínez P Angiology; 2020 Sep; 71(8):698-700. PubMed ID: 32242451 [No Abstract] [Full Text] [Related]
10. Advanced glycation and lipoxidation end products: reactive carbonyl compounds-related uraemic toxicity. Miyata T; Saito A; Kurokawa K; van Ypersele de Strihou C Nephrol Dial Transplant; 2001; 16 Suppl 4():8-11. PubMed ID: 11402090 [TBL] [Abstract][Full Text] [Related]
11. Carbamylated sortilin associates with cardiovascular calcification in patients with chronic kidney disease. Jankowski V; Saritas T; Kjolby M; Hermann J; Speer T; Himmelsbach A; Mahr K; Heuschkel MA; Schunk SJ; Thirup S; Winther S; Bottcher M; Nyegard M; Nykjaer A; Kramann R; Kaesler N; Jankowski J; Floege J; Marx N; Goettsch C Kidney Int; 2022 Mar; 101(3):574-584. PubMed ID: 34767831 [TBL] [Abstract][Full Text] [Related]
12. Avenues for post-translational protein modification prevention and therapy. Tang M; Kalim S Mol Aspects Med; 2022 Aug; 86():101083. PubMed ID: 35227517 [TBL] [Abstract][Full Text] [Related]
13. Advanced Glycation End Products: A Sweet Flavor That Embitters Cardiovascular Disease. Pinto RS; Minanni CA; de Araújo Lira AL; Passarelli M Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269546 [TBL] [Abstract][Full Text] [Related]
14. Advanced oxidation protein products, parathyroid hormone and vascular calcification in uremia. Drüeke TB; Massy ZA Blood Purif; 2002; 20(5):494-7. PubMed ID: 12207101 [TBL] [Abstract][Full Text] [Related]
15. Advanced glycation end products (AGEs) and cardiovascular dysfunction: focus on high molecular weight AGEs. Deluyker D; Evens L; Bito V Amino Acids; 2017 Sep; 49(9):1535-1541. PubMed ID: 28710551 [TBL] [Abstract][Full Text] [Related]
16. Advanced glycation end products as biomarkers for cardiovascular disease: browning clarifying atherogenesis. Pinto RS; Machado UF; Passarelli M Biomark Med; 2020 Jun; 14(8):611-614. PubMed ID: 32530293 [No Abstract] [Full Text] [Related]
17. Protein carbamylation in kidney disease: pathogenesis and clinical implications. Kalim S; Karumanchi SA; Thadhani RI; Berg AH Am J Kidney Dis; 2014 Nov; 64(5):793-803. PubMed ID: 25037561 [TBL] [Abstract][Full Text] [Related]
18. Role of Advanced Glycation Endproduct (AGE)-Receptor for Advanced Glycation Endproduct (RAGE) Axis in Cardiovascular Disease and Its Therapeutic Intervention. Yamagishi SI Circ J; 2019 Aug; 83(9):1822-1828. PubMed ID: 31366777 [TBL] [Abstract][Full Text] [Related]
19. Implication of advanced glycation end products (Ages) and their receptor (Rage) on myocardial contractile and mitochondrial functions. Neviere R; Yu Y; Wang L; Tessier F; Boulanger E Glycoconj J; 2016 Aug; 33(4):607-17. PubMed ID: 27277623 [TBL] [Abstract][Full Text] [Related]
20. Advanced glycation end product cross-linking: pathophysiologic role and therapeutic target in cardiovascular disease. Zieman S; Kass D Congest Heart Fail; 2004; 10(3):144-9; quiz 150-1. PubMed ID: 15184729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]